Immunomodulation exerted by cyclophosphamide is not interfered by N-acetyl cysteine

Int J Immunopharmacol. 1986;8(6):651-5. doi: 10.1016/0192-0561(86)90038-x.

Abstract

Metabolism of cyclophosphamide (Cy) by liver enzymes results in cytostatic products and acrolein, which exerts urotoxicity. Experiments were designed to determine which metabolites are responsible for Cy-induced immunomodulation. For this purpose, mice were treated simultaneously with Cy and N-acetyl-cysteine (NAC), a thiol compound which reacts with acrolein, and different immunological functions were assayed. Results show that NAC did not interfere with Cy effects on antibody-dependent cellular cytotoxicity (ADCC), NK activity, delayed-type hypersensitivity (DTH) or antibody production, indicating that modulation of these functions by Cy is mediated by its cytostatic metabolites.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology*
  • Adjuvants, Immunologic*
  • Animals
  • Antibody Formation / drug effects*
  • Antibody-Dependent Cell Cytotoxicity / drug effects
  • Cyclophosphamide / pharmacology*
  • Cystitis / immunology
  • Hemorrhage / immunology
  • Hypersensitivity, Delayed*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology
  • Leukemia P388 / immunology
  • Lymphocytes / drug effects
  • Lymphocytes / immunology*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred Strains

Substances

  • Adjuvants, Immunologic
  • Cyclophosphamide
  • Acetylcysteine